DAVIS, Calif., June 04, 2018 (GLOBE NEWSWIRE) -- Marrone Bio Innovations, Inc. (NASDAQ: MBII ) (MBI), a leading provider of bio-based pest management and plant health products for the agriculture, turf and ornamental and water treatment markets, is pleased to announce the launch of REGALIA CG, GRANDEVO CG and VENERATE CG, a portfolio of products designed to control highly destructive pests and diseases, including powdery mildew, mites, thrips and aphids, during Cannabis production and home gardening.
REGALIA CG, GRANDEVO CG and VENERATE CG are multi-state-approved and extremely effective biological crop protection solutions for clean green cultivation, with the ability to generate increased yield and improved quality by reducing stresses from plant disease and insect and mite pests to the plant. When incorporated into an Integrated Pest Management (IPM) program, these products can serve as the fundamental difference for successful growers.
"GRANDEVO and VENERATE are a game changer when it comes to IPM programs,” said Kyle Stamback, Director of Cultivation at NorthWestGrown i502 and owner of Lean Cultivation LLC. “I have eliminated all other preventive sprays and only use Grandevo and Venerate. These products have kept my gardens clean and my beneficial bugs happy. I’ve seen great results against all types of malice bugs, from leaf eaters to root aphids."
“REGALIA has been considered the go-to product for powdery mildew control in the Cannabis industry,” said Kyle. “When using Regalia on a consistent schedule, I have documented increased vigor and stalk size. Due to the overall plant health, my yields have been remarkable. As a result of tank mixing Regalia and other great products offered by MBI, my plants have never been healthier and my IPM has never been simpler.”
REGALIA CG, GRANDEVO CG and VENERATE CG also help grow operations care for their employees and the environment. They are harvest flexible and worker-friendly with a four-hour re-entry interval, minimal personal protective equipment requirements and the ability to be used right before harvest without concern for synthetic chemical residues.
“Outreach to hundreds of growers and industry leaders helped MBI create a solution that addresses needs in information sharing, education and training, ultimately producing products they can use with confidence backed by science,” said Lisa Malabad, Cannabis Segment Lead at Marrone Bio Innovations. “We continue to work with state regulatory agencies to ensure each of our products is aligned with all requirements and guidelines, giving growers peace of mind.”
REGALIA CG and VENERATE CG are available in one quart and one-gallon sizes. Grandevo CG is available in one and four-pound packages.
About Marrone Bio Innovations
Bio With Bite. Marrone Bio Innovations, Inc. (NASDAQ: MBII ) strives to lead the movement to a more sustainable world through the discovery, development and promotion of biological products for crop protection and plant health. MBI’s effective and environmentally responsible pest management solutions help customers operate more sustainably while uniquely improving plant health and increasing crop yields. MBI’s currently available commercial products are Regalia ® , Grandevo ® , Venerate ® , Majestene ® , Haven ® Stargus TM and Amplitude TM , Zelto ® and Zequanox ® .
Marrone Bio Innovations is dedicated to pioneering smart biopesticide solutions that support a better tomorrow for both farmers, turf managers and consumers around the globe. For more information, please visit www.marronebio.com .
Marrone Bio Innovations Forward Looking Statements This press release contains forward-looking statements that involve substantial risks and uncertainties. All statements, other than statements of historical facts, included in this press release regarding strategy, future operations and plans, including assumptions underlying such statements, are forward-looking statements, and should not be relied upon as representing MBI’s views as of any subsequent date. Examples of such statements include statements regarding the potential of Regalia, Grandevo and Venerate CG and other MBI products in the US and Canada, market projections, including the potential benefits of Regalia CG. Such forward-looking statements are based on information available to the Company as of the date of this release and involve a number of risks and uncertainties, some beyond the Company's control, that could cause actual results to differ materially from those anticipated by these forward-looking statements, including consumer, regulatory and other factors affecting demand for the MBI’s products, any difficulty in marketing MBI’s products in its target markets, competition in the market for pest management products, lack of understanding of bio-based pest management products by customers and growers. Additional information that could lead to material changes in MBI’s performance is contained in its filings with the SEC. MBI is under no obligation to, and expressly disclaims any responsibility to, update or alter forward-looking statements contained in this release, whether as a result of current information, future events or otherwise.
Marrone Bio Innovations Contacts: Kevin Hammill, Chief Commercial Officer Keith Pitts, Sr. VP of Regulatory and Government Affairs and Chief Sustainability Officer Lisa Malabad, Product Marketing Manager and Cannabis Segment Lead Telephone: +1 (530) 750-2800 Email: Info@marronebio.com
MBI Investor Relations: Greg Falesnik Managing Director MZ Group – MZ North America Main: 949-385-6449 MBII@mzgroup.us www.mzgroup.us
